NHS England in legal battle with American firm over medicine procurement

NHS England

7 November 2018 - An American pharmaceutical company has launched a legal challenge against NHS England over a procurement process seeking suppliers for ground-breaking hepatitis C treatment.

The legal proceedings were launched by the American firm Abbvie in London’s Technology and Construction Court during the summer, claiming that NHS England breached its duty to treat all bidders fairly.

The procurement was launched in spring in a bid to lower the cost of hepatitis C drugs which are manufactured by Abbvie, MSD, Janssen and Gilead Sciences.

Read National Health Executive article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

England , Medicine , Process , Funding